Cargando…

“Should I Inhale?”—Perceptions, Barriers, and Drivers for Medicinal Cannabis Use amongst Australian Women with Primary Dysmenorrhoea: A Qualitative Study

Objective: This study sought to investigate the perceptions, barriers, and drivers associated with medicinal cannabis use among Australian women with primary dysmenorrhea. A qualitative study via virtual focus groups involving 26 women experiencing regular, moderate, or greater menstrual pain explor...

Descripción completa

Detalles Bibliográficos
Autores principales: Sinclair, Justin, Armour, Susanne, Akowuah, Jones Asafo, Proudfoot, Andrew, Armour, Mike
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8835209/
https://www.ncbi.nlm.nih.gov/pubmed/35162564
http://dx.doi.org/10.3390/ijerph19031536
_version_ 1784649373123084288
author Sinclair, Justin
Armour, Susanne
Akowuah, Jones Asafo
Proudfoot, Andrew
Armour, Mike
author_facet Sinclair, Justin
Armour, Susanne
Akowuah, Jones Asafo
Proudfoot, Andrew
Armour, Mike
author_sort Sinclair, Justin
collection PubMed
description Objective: This study sought to investigate the perceptions, barriers, and drivers associated with medicinal cannabis use among Australian women with primary dysmenorrhea. A qualitative study via virtual focus groups involving 26 women experiencing regular, moderate, or greater menstrual pain explored categories including cost, associated stigma, current drug driving laws, community and workplace ethics, and geographical isolation within the context of patient access under current Australian laws and regulations. Results: A qualitative descriptive analysis identified that dissatisfaction with current management strategies such as over-the-counter analgesic usage was the key driver for wanting to use medicinal cannabis. A number of significant barriers to use were identified including patient access to medical prescribers, medical practitioner bias, current drug driving laws, geographic location, and cost. Community and cultural factors such as the history of cannabis as an illicit drug and the resulting stigma, even when prescribed by a medical doctor, still existed and was of concern to our participants. Conclusion: Whilst medicinal cannabis is legal in all states and territories within Australia, several barriers to access exist that require government regulatory attention to assist in increasing patient adoption, including possible subsidisation of cost. The high cost of legal, medicinal cannabis was a key factor in women’s choice to use illicit cannabis. Overall, the concerns raised by our participants are consistent with the broader findings of a recent Australian Senate inquiry report into barriers to patient access to medicinal cannabis in Australia, suggesting many of the issues are systematic rather than disease-specific. Given the interest in use of medicinal cannabis amongst women with primary dysmenorrhea, clinical trials in this area are urgently needed.
format Online
Article
Text
id pubmed-8835209
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-88352092022-02-12 “Should I Inhale?”—Perceptions, Barriers, and Drivers for Medicinal Cannabis Use amongst Australian Women with Primary Dysmenorrhoea: A Qualitative Study Sinclair, Justin Armour, Susanne Akowuah, Jones Asafo Proudfoot, Andrew Armour, Mike Int J Environ Res Public Health Article Objective: This study sought to investigate the perceptions, barriers, and drivers associated with medicinal cannabis use among Australian women with primary dysmenorrhea. A qualitative study via virtual focus groups involving 26 women experiencing regular, moderate, or greater menstrual pain explored categories including cost, associated stigma, current drug driving laws, community and workplace ethics, and geographical isolation within the context of patient access under current Australian laws and regulations. Results: A qualitative descriptive analysis identified that dissatisfaction with current management strategies such as over-the-counter analgesic usage was the key driver for wanting to use medicinal cannabis. A number of significant barriers to use were identified including patient access to medical prescribers, medical practitioner bias, current drug driving laws, geographic location, and cost. Community and cultural factors such as the history of cannabis as an illicit drug and the resulting stigma, even when prescribed by a medical doctor, still existed and was of concern to our participants. Conclusion: Whilst medicinal cannabis is legal in all states and territories within Australia, several barriers to access exist that require government regulatory attention to assist in increasing patient adoption, including possible subsidisation of cost. The high cost of legal, medicinal cannabis was a key factor in women’s choice to use illicit cannabis. Overall, the concerns raised by our participants are consistent with the broader findings of a recent Australian Senate inquiry report into barriers to patient access to medicinal cannabis in Australia, suggesting many of the issues are systematic rather than disease-specific. Given the interest in use of medicinal cannabis amongst women with primary dysmenorrhea, clinical trials in this area are urgently needed. MDPI 2022-01-29 /pmc/articles/PMC8835209/ /pubmed/35162564 http://dx.doi.org/10.3390/ijerph19031536 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Sinclair, Justin
Armour, Susanne
Akowuah, Jones Asafo
Proudfoot, Andrew
Armour, Mike
“Should I Inhale?”—Perceptions, Barriers, and Drivers for Medicinal Cannabis Use amongst Australian Women with Primary Dysmenorrhoea: A Qualitative Study
title “Should I Inhale?”—Perceptions, Barriers, and Drivers for Medicinal Cannabis Use amongst Australian Women with Primary Dysmenorrhoea: A Qualitative Study
title_full “Should I Inhale?”—Perceptions, Barriers, and Drivers for Medicinal Cannabis Use amongst Australian Women with Primary Dysmenorrhoea: A Qualitative Study
title_fullStr “Should I Inhale?”—Perceptions, Barriers, and Drivers for Medicinal Cannabis Use amongst Australian Women with Primary Dysmenorrhoea: A Qualitative Study
title_full_unstemmed “Should I Inhale?”—Perceptions, Barriers, and Drivers for Medicinal Cannabis Use amongst Australian Women with Primary Dysmenorrhoea: A Qualitative Study
title_short “Should I Inhale?”—Perceptions, Barriers, and Drivers for Medicinal Cannabis Use amongst Australian Women with Primary Dysmenorrhoea: A Qualitative Study
title_sort “should i inhale?”—perceptions, barriers, and drivers for medicinal cannabis use amongst australian women with primary dysmenorrhoea: a qualitative study
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8835209/
https://www.ncbi.nlm.nih.gov/pubmed/35162564
http://dx.doi.org/10.3390/ijerph19031536
work_keys_str_mv AT sinclairjustin shouldiinhaleperceptionsbarriersanddriversformedicinalcannabisuseamongstaustralianwomenwithprimarydysmenorrhoeaaqualitativestudy
AT armoursusanne shouldiinhaleperceptionsbarriersanddriversformedicinalcannabisuseamongstaustralianwomenwithprimarydysmenorrhoeaaqualitativestudy
AT akowuahjonesasafo shouldiinhaleperceptionsbarriersanddriversformedicinalcannabisuseamongstaustralianwomenwithprimarydysmenorrhoeaaqualitativestudy
AT proudfootandrew shouldiinhaleperceptionsbarriersanddriversformedicinalcannabisuseamongstaustralianwomenwithprimarydysmenorrhoeaaqualitativestudy
AT armourmike shouldiinhaleperceptionsbarriersanddriversformedicinalcannabisuseamongstaustralianwomenwithprimarydysmenorrhoeaaqualitativestudy